JACC. Case reports
Rechallenge With Cisplatin After an Acute Coronary Event.
Zehra Jaffery, Rick L Jobski, Richard S Siegel, Anju Nohria
Published: 202610.1016/j.jaccas.2025.106591
Abstract
BACKGROUND: Testicular cancer is the most common malignancy in young men, and cisplatin-based chemotherapy provides excellent long-term survival. However, cisplatin-associated cardiovascular toxicity spans a broad spectrum, and evidence guiding recha…
Preview only. Read the full abstract at the source